Agent for treatment of cerebrovascular contraction
US5238964A · kind A · utility
2Cited by
10References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1992 |
| Grant date | Aug 24, 1993 |
| Priority date | — |
| Expiry date | Feb 13, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of cerebrovascular contraction in mammals involving administration of a pharmaceutical composition containing as an effective ingredient a p-guanidinobenzoic acid derivative represented by the formula ##STR1## wherein R denotes a group represented by the formula ##STR2## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.